Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism
Frontiers in Pharmacology · 26.08.2025 · 16
DOI: 10.3389/fphar.2025.1641838 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Pharmacology, online erschienen am 26.08.2025. Verfasst von Hongjin Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 148 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Melanoma is one of the most common malignancies among fair-skinned populations. Natural products, a diverse group of bioactive compounds derived from plants and animals, have demonstrated inhibitory effects on melanoma growth, invasion, and metastasis. This review summarizes the mechanisms through which natural products inhibit melanoma progression and metastasis. These compounds are categorized based on their mechanisms of action. Many natural products have been found to induce apoptosis in melanoma cells through various signaling pathways. For instance, rhodopsin and the triazolylpeptidyl penicillin derivative TAP7f suppress the Wnt/β-catenin signaling pathway, thereby reducing melanoma cell proliferation and migration. Resveratrol and vitamin E delta-tocotrienol (δ-TT) inhibit caspase-dependent mitochondrial and endoplasmic reticulum stress pathways, inducing apoptosis in melanoma cells. Shikonin and plumbagin exert their antitumor effects through the mitogen-activated protein kinase/extracellular signal-regulated kinase (MAPK/ERK) signaling pathway. In addition, natural products such as silymarin, capsaicin, and ursolic acid exhibit multi-targeted anticancer effects with high efficiency and low toxicity by modulating various signaling pathways. These findings highlight the ability of natural compounds to regulate multiple biological targets, offering new directions and potential clinical applications in melanoma therapy. Natural product–based drug development holds great promise for overcoming current limitations in cancer treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Chengdu Integrated TCM & Western Medicine Hospital, Chengdu, Sichuan, China.
- Dermatology Department of Bijie Traditional Chinese Medicine Hospital, Guiyang, Guizhou, China.
Zitieren
APA
Gao, H., Huang, J., Zhang, D., Li, S., Long, S., & Qin, Y. (2025). Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism. Frontiers in Pharmacology, 16. https://doi.org/10.3389/fphar.2025.1641838
Vancouver
Gao H, Huang J, Zhang D, Li S, Long S, Qin Y. Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism. Frontiers in Pharmacology. 2025;16. doi:10.3389/fphar.2025.1641838
BibTeX
@article{Gao2025,
author = {Gao, Hongjin and Huang, Jianli and Zhang, Dengfeng and Li, Sixuan and Long, Shengzhi and Qin, Yuesi},
title = {Natural products as therapeutics for malignant melanoma: preclinical evidence and mechanism},
journal = {Frontiers in Pharmacology},
year = {2025},
volume = {16},
doi = {10.3389/fphar.2025.1641838}
}
EUVIMED